Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
Quizartinib plus chemotherapie bij nieuw gediagnosticeerde FLT3-ITD-positieve AML
jul 2023 | Leukemie